Multiplicom specializes in technology for genetic tests, and develops, produces and commercializes molecular-diagnostic kits that enable personalized healthcare. “By acquiring Multiplicom, we strengthen our position on the genomics market,” explains Herman Verrelst, vice president and general manager of Agilent’s Genomics Division. “Multiplicom’s products and technology broadens and enriches our portfolio, creating a lot of potential in Flanders’ neighboring markets.”